The life expectancy of a person with myelodysplastic syndrome can vary widely according to their risk level on one of the two scoring systems used to predict the outlook for people with these cancers. The median survival rating can vary from less than one year to almost 12 years, depending on a person's score. It's also important to note these statistics improve over time as treatments improve.